Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2009
10/22/2009US20090264636 Conjugates and compositions for cellular delivery
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264533 Methods and Compositions for Modulating RHO-Mediated Gene Transcription
10/22/2009US20090264511 Compositions and methods for inhibiting expression of factor vii gene
10/22/2009US20090264487 Hemiasterlin analogs
10/22/2009US20090264486 Compounds, Compositions and Methods Comprising Isoxazole Derivatives
10/22/2009US20090264481 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/22/2009US20090264455 Androgen Receptor Modulator Compounds and Methods
10/22/2009US20090264433 Compounds, Compositions and Methods Comprising Triazine Derivatives
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264356 Adenovirus 36 E4 orf 1 Gene and Protein and Their Uses
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264344 cyclic polypeptide biodrug; NONHEMOLYTIC, MINIMAL IN VITRO CYTOTOXICITY; TREATMENT OF BACTERIAL, VIRAL INFECTION, ESPECIALLY ONE CAUSED BY HIV-1 RETROVIRUS OR OTHER SEXUALLY-TRANSMITTED PATHOGENS
10/22/2009US20090264342 Compositions and methods for antibiotic potentiation and drug discovery
10/22/2009US20090264319 Method for the analysis of exclusive gene expression profile using a trace amount of sample
10/22/2009US20090264312 Method for removing desired chromosome and tailor-made medical treatment utilizing the same
10/22/2009US20090264311 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/22/2009US20090264309 Methods for Screening for Compounds that Modulate Insulin Promoter Activity
10/22/2009US20090264305 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
10/22/2009US20090264304 Normalized nucleic acid libraries and methods of production thereof
10/22/2009US20090263901 Stable neural stem cell lines
10/22/2009US20090263899 Cell modification method and cell modification device
10/22/2009US20090263898 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/22/2009US20090263897 Reishi f3 sub fraction polysaccharides and methods of using same
10/22/2009US20090263896 Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
10/22/2009US20090263895 Cell line for producing a non-retroviral vector
10/22/2009US20090263894 Antibodies that bind to mammalian ngal and uses thereof
10/22/2009US20090263878 Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
10/22/2009US20090263875 Methods of generating protein variants with altered function
10/22/2009US20090263865 Substance Specific to Human PD-1
10/22/2009US20090263860 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cell proliferative disorders
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263835 Genes that are Up- or Down-Regulated During Differentiation of Human Embryonic Stem Cells
10/22/2009US20090263832 Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling Pathways
10/22/2009US20090263812 Use of id4 for diagnosis and treatment of cancer
10/22/2009US20090263554 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
10/22/2009US20090263516 Plant Extract Composition and Their Use to Modulate Cellular Activity
10/22/2009US20090263452 Drug-eluting intravascular prostheses and methods of use
10/22/2009US20090263429 Method of Preparing a Hydrogel
10/22/2009US20090263428 Artificial lymph node for treating cancer
10/22/2009US20090263425 Methods of stimulating an immune response against prostate specific antigen
10/22/2009US20090263421 Cellular vaccine
10/22/2009US20090263412 Non-Splicing Variants of gp350/220
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263402 Growth Differentiation Factor-11
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263394 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
10/22/2009US20090263392 Methods of modifying antibodies for purification of bispecific antibodies
10/22/2009US20090263383 Antibodies to angiogenesis inhibiting domains of CD148
10/22/2009US20090263382 Stable and soluble antibodies inhibiting tnf alpha
10/22/2009US20090263380 Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
10/22/2009US20090263375 Novel poly(a) polymerase
10/22/2009US20090263365 Methods and compositions for transforming dendritic cells and activating cells
10/22/2009US20090263364 Method and constructs for delivering double stranded rna to pest organisms
10/22/2009US20090263363 Compositions and Methods For Treating Bone Formation Disorders
10/22/2009US20090263362 Fertility enhancement using lipid carriers and bioactive molecules
10/22/2009US20090263361 Isolating ectopic pregnant mass-derived human villous trophoblast stem cell; expresses embryonic stem cell antigens SSEA-1, SSEA-3 and SSEA-4; neurodegenerative disease
10/22/2009US20090263360 Neuronal progenitors from feeder-free human embryonic stem cell culture
10/22/2009US20090263359 Particulate Delivery Vehicles for Embryoid Bodies
10/22/2009US20090263357 Therapeutic Reprogramming, Hybrid Stem Cells and Maturation
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009US20090263318 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
10/22/2009CA2721585A1 A concentrated medium and its usage
10/22/2009CA2721256A1 Magnetic particles
10/22/2009CA2720980A1 Methods for enhanced production of bone morphogenetic proteins
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110431A1 Cartilage regeneration using human mesenchymal stem cells
10/21/2009EP2110385A1 Stabilized factor VIII with engineered disulfide bonds
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2109668A2 Human cancer stem cells
10/21/2009EP2109667A2 Extracellular matrix cancer vaccine adjuvant
10/21/2009EP1960777B1 Serum-free expansion of cells in culture
10/21/2009EP1666586B1 Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1648521B1 Compositions and methods for treating cardiac dysfunction
10/21/2009EP1590467B1 Use of regulatory sequences for specific, transient expression in neuronal determined cells
10/21/2009EP1516050B1 Generation of plants with improved pathogen resistance
10/21/2009EP1501465B1 Vectors having both isoforms of beta-hexosaminidase
10/21/2009EP1499885B1 Novel fusion proteins and assays for molecular binding
10/21/2009EP1496118B1 Method of measuring human cyp3a inducibility
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1392359B1 Specific binding proteins and uses thereof
10/21/2009EP1292680B1 Agonist anti-trk-c monoclonal antibodies
10/21/2009EP1169462B1 Oil comprising brassicastanol
10/21/2009EP1025241B2 Multiply-substituted protease variants
10/21/2009EP1007743B1 Enzymes mixture
10/21/2009CN101563450A Method for preparing a cell-derived extracellular matrix membrane
10/21/2009CN101563449A Stem cell culture medium and method
10/21/2009CN101563366A Anti-NOTCH3 agonist antibodies and their use in the treatment of NOTCH3-related diseases
10/21/2009CN101561443A Five-classification leucocyte simulacrum particle, method for preparing same, and quality control substance and calibration substance containing same
10/21/2009CN101560517A Preparation process of interleukin-2 genetic engineering gastric carcinoma cell tumour vaccine
10/21/2009CN101560507A Phosphate transferase and encoding gene and application thereof
10/21/2009CN101560504A Canola plant over-long chain fatty acid synthetase and application thereof
10/21/2009CN101560500A Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 1827